Introduction
The genetic alterations associated with initiation and progression of colorectal cancer are well-defined and have provided a paradigm for the multistep nature of cancer development (1, 2) . However, the inability to maintain normal colorectal epithelial cells in culture has hampered the assessment of the oncogenic potential of the various genetic abnormalities identified in primary tumors or in tumor-derived cell lines. The colonic mucosa has proved difficult to study because this tissue is often heavily contaminated by bacteria and fungi and because the proliferative cells constitute a single layer lying deep in the crypts of Leiberkuhn. Despite attempts to develop longterm cultures of colonic epithelial cells from different species (3) (4) (5) , proliferation of these cells has not been demonstrated for more than a few days (6, 7) . There have been attempts to immortalize or transform intestinal epithelial cells by using known immortalizing viral proteins (8) . For example, conditionally immortalized epithelial cell lines have been obtained from the colon of transgenic mice bearing a temperature-sensitive mutation of the simian virus 40 large tumor antigen gene (9) . To overcome the difficulties of culturing normal colonic mucosal cells in vitro and to establish a long-term culture, we used tissues derived from young mice harboring an homozygous disruption of the p53 gene. These mice develop spontaneous lymphomas with high frequency before reaching the age of 6 mo, but not colon cancer or other types of carcinomas (10) . Mutation of p53 is a common genetic abnormality acquired late in the development of colorectal cancer, and it is often detected in tumors carrying activating mutations of the Ki-ras oncogene (1) . Nevertheless, it is not an absolute requirement that the genetic changes leading to colorectal cancer occur in a sequential order (1) . Moreover, suppression of colorectal cancer cell growth can be achieved by inhibiting the expression of activated oncogenes (11) or by restoring the function of tumor suppressor genes (12, 13) , without the hierarchy of effects that might be expected on the basis of a preferred order of appearance of genetic changes.
In this study, we induced tumorigenic conversion of colon epithelial cells from p53-deficient mice by retroviral-mediated introduction of an oncogenic Ki-ras mutant (14) . After infection with the activated Ki-ras, neoplastic conversion of p53-deficient epithelial cells was readily obtained and the Ki-ras-transformed cells produced tumors in mice resembling colorectal cancer. These data lend support to the pathogenetic role of p53 and RAS mutations in colorectal cancer. Moreover, this model of colorectal cancer that depends on two defined events (loss of p53 function and expression of an activated Ki-ras gene) is well-suited for the assessment of novel antitumor therapeutic strategies.
Methods
Mice. Seven p53 knock-out (four female, three male) and four p53 ϩ / Ϫ (two female, two male) mice 8-12 wk old were used to generate cultures of primary colon epithelial cells and derivatives after infection with the Ki-ras-containing retrovirus (see below). Genotyping of the mice was carried out by standard methods of genomic DNA isola-tion from the tails of 1-mo-old mice, followed by PCR amplification of the wild-type (p53 ϩ / ϩ ) or the knock-out (p53 Ϫ / Ϫ ) allele with specific primers as described (15) .
Crypt isolation and culture techniques. Crypts were isolated from colonic intestinal mucosa by using a nonenzymatic technique (6) . Briefly, the colon was removed from 8-12-wk-old mice and flushed with 0.1 M calcium-magnesium free PBS to remove soiling. The colon was opened by longitudinal incision, soaked in 0.04% sodium hypochlorite for 30 min to kill bacteria and fungi, washed three times in PBS, cut into small pieces ‫ف‬ 0.5 ϫ 1.5 mm, and placed in a tube with 20 ml of PBS containing 1 mM EDTA, 1 mM EGTA, and 0.5 mM DDT. After incubation at room temperature for 90 min with occasional shaking, the solution was removed carefully and replaced with PBS. The tube with the organ was vigorously shaken to detach the crypts from the underlying stroma until the majority of the crypts was released. All collected crypts were pooled and suspended in DME/ nutrient mixture F-12 (HAM) supplemented with 10% FCS (GIBCO BRL, Gaithersburg, MD), 2 mM glutamine, 50 g/ml penicillin/streptomycin, 10% conditioned medium from 48-h cultures of the mouse rectum carcinoma cell line CMT-93 (American Type Culture Collection, Rockville, MD), 1 mM sodium pyruvate, 15 mM Hepes [pH 7.5], 0.1 mM nonessential amino acids, 20 g/ml EGF, 6 g/ml insulin, 6 g/ml transferrin, 1 g/ml hydrocortisone, 5 g/ml cholera toxin, 0.05 mM 2-mercaptoethanol, and 10 M of the ICE inhibitor tetrapeptide YVAD added only in the early stages of the culture. The crypts were plated at a density of ‫ف‬ 250 crypts/cm 2 into mouse collagen type IVcoated 25 cm 2 flasks (Collaborative Biomedical Products, Bedford, MA) containing a feeder layer made of a 3:1 mix of NIH 3T3 fibroblasts and colon-derived fibroblasts from the same strain of the p53 knock-out mice, treated with 10 g/ml mitomycin C. The crypts were allowed to settle overnight in a minimal volume of medium at 37 Њ C in an atmosphere of 5% CO 2 . After overnight incubation, the volume of the culture medium was increased to 5 ml. New feeder layer was added every week. When cells formed a clone with a diameter of ‫ف‬ 3 cm, the culture was trypsinized and transferred into two 35-mm mouse collagen type IV-coated tissue culture dishes containing the feeder layer described above. Contaminating colon fibroblasts were removed from the culture using 0.25% trypsin, which selectively releases fibroblasts from the culture surface, leaving epithelial cells attached to the bottom of the dish. Some of the fibroblasts were also physically removed by scraping or by aspiration. All these procedures were repeated until only epithelial-like cells remained in the culture and no fibroblasts were seen under the microscope. The medium was changed every other day and cells were passaged when confluent. Early passages of the culture were split at 1:3. Fibroblasts were also obtained from the same colon by the primary explant culture technique. The cultures were tested for the presence of mycoplasma using an ELISA detection kit (Boehringer Mannheim Biochemicals, Indianapolis, IN).
Plasmid construct. The cDNA corresponding to the Ki-ras2 transforming allele (glycine to valine substitution at the 12th amino acid of the RAS protein) present in the human colon carcinoma cell line SW480 (SW11-1) (14) was obtained from American Type Culture Collection. The Ki-ras2-containing plasmid SW11-1 was linearized by PstI and then Klenow-blunted. Thereafter, the linearized SW11-1 plasmid was BamHI-digested and the 1.1-kb Ki-ras2 cDNA was released, gel purified, and ligated into the pLXSN vector digested with EcoRI, blunted, and digested with BamHI. In the pLXSN vector (16) , the expression of Ki-ras2 was under the control of the long terminal repeat of the M-MLV, while the expression of the NEO resistance gene was driven by the simian virus 40 early promoter. The cDNA of human wild-type p53 and the R248W mutant were obtained from B. Vogelstein (Johns Hopkins University School of Medicine, Baltimore, MD), and cloned into the HpaI site of the LXSP vector.
Preparation of viral stock. pLXSN/Ki-ras2 was electroporated into the GP ϩ E86 packaging line (17) and ecotropic recombinant retrovirus-producing cells were obtained after 2-3 wk of selection in G418-containing medium (1 mg/ml). Viral stock containing supernatants was collected 3 d after formation of 80% confluent monolayer in DME/F-12 (HAM) medium supplemented with 0.05 mM 2-mercaptoethanol. Titers of the viral stocks were determined by infecting Rat-2 cells and scoring the number of G418-resistant colonies. The titer of the virus used in the experiments was 8 ϫ 10 3 cfu/ml. Retroviral infection of p53 Ϫ / Ϫ epithelial cultures. A 70% confluent monolayer of primary epithelial cells (fifth passage) from colonic crypts was trypsinized, washed, and replated in the same (60-mm) tissue culture dish. The next day, cells were infected with retroviral supernatants for 72 h in the presence of polybrene (Sigma Chemical Co., St. Louis, MO). The supernatants were changed every 6 h and the concentration of polybrene was 20 g/ml for 12 h and 10 g/ml for the next 12 h each day. After 72 h, the supernatant was removed and replaced with culture medium for 24 h. The next day, G418 (GIBCO BRL) was added at 1-2 mg/ml, depending on the density of the monolayer. Uninfected p53 Ϫ / Ϫ cells died when G418 was added at a concentration Ն 1 mg/ml, despite bearing a NEO gene within each p53 allele. Fifth passage p53 knock-out fibroblasts derived from the colon explants were also infected with the same retrovirus. A 70% monolayer was trypsinized and replated in the same tissue culture dish (35-mm). The next day, cells were infected with the viruscontaining supernatant for 48 h in the presence of 8 g/ml polybrene (Sigma Chemical Co.). The supernatants were changed approximately every 6 h. Clones of infected cells were selected by adding G418 at 1.5 mg/ml. Integration of the Ki-RAS-containing retrovirus was established by PCR amplification of genomic DNA using a 5 Ј primer (5 Ј GCCTCGACTCTCCCTTTATCC 3 Ј ) located in the pLXSN vector upstream of the Ki-RAS insert and a 3 Ј primer (5 Ј GTCCTGAGCCTGTTTTGTGTC 3 Ј ) corresponding to nucleotides 378-398 of the Ki-ras2 coding sequence (14) .
Colony formation assays of Ki-ras-infected p53 Ϫ / Ϫ epithelial cells. Cells (14th passage) were seeded at a density of 7.5 ϫ 10 5 /100-mm petri dishes in duplicate. Cells were grown for 16 h in DME/nutrient mixture F-12 (HAM) (GIBCO BRL) supplemented with 10% FCS (Sigma Chemical Co.), 1 mM sodium pyruvate (Sigma Chemical Co.), 15 mM Hepes (GIBCO BRL), 0.1 mM nonessential amino acids (GIBCO BRL), 10 ng/ml EGF (Sigma Chemical Co.), 3 g/ml insulin (Sigma Chemical Co.), 3 g/ml transferrin (Sigma Chemical Co.), 0.5 g/ml hydrocortisone (Sigma Chemical Co.), 2.5 g/ml cholera toxin (Sigma Chemical Co.), 0.1 ng/ml triiodothyronine (Sigma Chemical Co.), and 0.05 mM 2-mercaptoethanol (GIBCO BRL). Cells were transfected by standard calcium phosphate precipitation (18) with 20 g each of wild-type or mutant (R248W) p53 cDNA. DNA precipitates were left on the cells for 12 h. Cells were then washed with PBS and cultured in fresh media in the presence of puromycin (3 g/ml) for 2 wk. Colonies were washed with PBS and stained with methylene blue in 50% methanol for 10 min.
Ultrastructural studies of cells grown within collagen. For ultrastructural studies, control colonic epithelial cells and their retrovirally infected counterparts were cultured within a collagenous matrix essentially as described (19) with minor modifications. Bovine dermal collagen (Vitrogen 100, 3 mg/ml) dissolved in 0.012 N HCl was purchased from Celtrix, Inc. (Santa Clara, CA). A collagen mix containing Vitrogen 100, 10% 8 ϫ DME, and 4% Matrigel (Collaborative Biomedical Products) was prepared and stored on ice. Each well of a 24-well plate was coated with 0.2 ml of collagen gel mix and the plate was incubated at 37 Њ C for 1 h to allow the collagen to gel. Approximately 3 ϫ 10 5 cells were mixed with 0.2 ml collagen mix and overlaid on a previously collagen-coated well. The cell suspension in collagen was allowed to gel for 1 h at 37 Њ C and then 0.7 ml medium was added to the culture. The medium was changed after 4 h and thereafter every 2 d. After 5 or 6 d of incubation, the cultures were fixed with 2.5% ice-cold glutaraldehyde. The collagen gels could then be lifted out with a spatula and placed in a vial of fixative before processing for transmission electron microscopy (19) .
Soft agar assays. Primary epithelial cell cultures (eighth passage) infected or noninfected with the Ki-ras retrovirus were harvested for agar cloning. The clonal agar culture was performed in a double-layer agar system. 1 ml basal layer culture medium with a final 0.5% agarose (GIBCO BRL) concentration was prepared in 35-mm 2 plastic Petri dishes. Approximately 5 ϫ 10 3 /ml viable cells (five replicates) in 1 ml upper layer medium (0.2% agarose) were overlaid onto the preformed basal layer. Dishes were incubated for Ͻ 21 d at 37 Њ C in a humidified atmosphere of 5% CO 2 . The colonies were sized with a calibrated eye-piece grid with the use of an Olympus CK2 inverted microscope at a magnification of 100. Colonies with a diameter Ն 125 m were counted after 1 and 2 wk.
Xenograft studies. Uninfected, LXSN-infected, and Ki-ras-infected p53 Ϫ / Ϫ colon epithelial cells (eighth passage) were inoculated (10 6 cells in 150 l PBS) under the skin of both flanks of five Fox Chase ICR SCID™ outbred male mice [Tac:Icr:Ha(ICR)-scidfDF]. In a second experiment, 15 additional mice (5 mice in each group) were inoculated with 10 6 infected and noninfected colon epithelial cells (11th passage). Five SCID mice were also inoculated with 10 6 cells of the mouse rectum carcinoma line CMT-93. Tumor growth was assessed twice weekly by microcaliper measurement. Tumor tissue was fixed in 10% buffered formaldehyde and processed for routine histology (20) .
RT-PCR detection of endogenous Ki-ras. Total RNA from p53 Ϫ / Ϫ colon epithelial cell cultures (eighth passage) was reverse transcribed using M-MLV reverse transcriptase (GIBCO BRL), dNTPs, and random primers. The Ki-ras double-stranded cDNA was amplified by PCR using primers specific for both forms of Ki-ras mRNA generated by alternative splicing (21) . The PCR products were subcloned into the pCR II vector (Invitrogen Corp., Carlsbad, CA) and sequenced. The primers used were:
The 5 Ј primer is common for both Ki-RAS mRNA transcripts; primer 3 Ј A corresponds to the 3 Ј end of exon 4a, while primer 3 Ј B corresponds to 3 Ј end of exon 4b.
Western blotting. 10 6 cells obtained from each culture were lysed in lysing buffer (1% NP-40, 0.15 NaCl, 0.01M Hepes [pH 7.5], 10% glycerol) with proteinase inhibitors (1 mM PMSF, 10 g/ml aprotinin, 10 g/ml leupeptin, 1 mM sodium orthovanadate, 0.5 mM EDTA). Protein lysates were immunoprecipitated on Agarose coated with anti-H-Pan-ras antibody (Oncogene Science Inc., Manhasset, NY) and then run on 17.5% SDS-PAGE, transferred on nitrocellulose membrane (Schleicher & Schuell, Keene, NH), and blocked as described (22). In the same experiments, when the total amount of proteins was Ͼ 100 g, incubation with the Pan-ras antibody (Oncogene Science) followed by washing and incubation with the secondary antibody were according to manufacturer's protocols. Immunoreactivity was determined using the ECL kit (Amersham, Arlington Heights, IL).
Results

Establishment of epithelial cell cultures from crypts of p53
knock-out mice. During the first 48 h after the isolation of mouse colon crypts, epithelial cells surrounded by the fibroblast feeder layer attached to collagen type IV-coated plates. The majority of the attached cells died during the first 2-3 wk, and only a small number of cells continued to grow, but longterm primary cultures with epithelial-like morphology were reproducibly obtained when crypts of young p53 knock-out mice were used and the feeder layers were freshly prepared. The morphology of the cells was epithelial-like, with typical cuboi- dal shape (Fig. 1 A ) . The epithelial-like cells could be readily distinguished from the slender fibroblasts of the feeder layer ( Fig. 1 A , arrowheads ) . They exhibited a cobblestone pattern typically observed in closely adhering cells (Fig. 1 B ) . When the epithelial cells reached a high density, they were passaged on mouse collagen type IV-or rat tail collagen type I-coated dishes or flasks, in the absence of the fibroblast feeder layer. After nine passages in collagen type IV-coated plates, the cells could be grown routinely at lower density in regular tissue culture dishes or flasks (Fig. 1 B ) . Most of the cells exhibited a clear cytoplasm and oval clear nuclei with distinct nucleoli. In addition, multinucleate cells were detectable among the monolayer cell culture. The epithelial nature of the cells was confirmed by immunostaining with a polyclonal Pancytokeratin antibody (data not shown). The histogenetic origin as colon epithelial cells of the primary culture was confirmed by transmission electron microscopy. The cultured cells formed anastomosing cords and tubelike structures (Fig. 2, A and B ) with pleomorphic lumina often lined by well-developed surface microvilli ( Fig. 2 A , arrowheads ) . The cells exhibited tight junctions (Fig. 2 C ) , prominent Golgi complexes and intermediate filaments (Fig. 2 D ) , and well-developed desmosomes (Fig.  2 E ) . Tight junctions, also known as zonula occludens, are characteristically found on the boundary between epithelial cells near the luminal surface and form a continuous belt-like region of close membrane contacts encircling the apex of the cells (23) . The presence of lumina sealed by tight junctions, the obvious polarization of the cells, and the presence of abundant microvilli unequivocally prove the epithelial nature of these cells.
Infection of p53-deficient colon epithelial cells with a retrovirus expressing an activated Ki-ras. Colon epithelial cell cultures established from the crypts of p53-deficient mice as described above were infected with the supernatant of GP-E86 packaging cells transfected with the retroviral vector carrying the activated Ki-ras gene. Before infection with the Ki-ras retrovirus, RT-PCR amplification and sequencing of the endogenous Kiras mRNA revealed that the Ki-ras gene remained in the wildtype form in the p53 Ϫ/Ϫ colon epithelial cells (data not shown). After selection in G418-containing medium, mixed cell populations were expanded and assessed for retroviral integration and expression of mutant Ki-RAS (Fig. 3) . As indi- cated by PCR analysis using 5Ј and 3Ј primers located in the retroviral vector and in the Ki-ras insert, respectively, the p53-deficient epithelial cells showed the product of PCR amplification expected in retrovirally infected cells (Fig. 3 A) . Moreover, expression of the mutant Ki-ras protein was detected in the infected cells (Fig. 3 B) by Western blot analysis with a monoclonal antibody [pan-RAS Val-12 (Ab-1); Oncogene Science] which distinguishes wild-type from mutant p21 RAS.
To determine whether the outgrowth of Ki-ras-infected p53 Ϫ/Ϫ epithelial cells was due to the expansion of a clonal or oligoclonal population of transformed cells, more than 50 "clones" were obtained by limiting dilution of a mixed cell population (10th passage) of Ki-ras-infected p53 Ϫ/Ϫ cells. When the clones reached a number in excess of 10 6 cells, genomic DNA was isolated and, after digestion with the restriction enzyme BamHI, hybridized with a 32 P-labeled fragment corresponding to the NEO cassette of the LXSN retroviral vector. A single band corresponding to the NEO-containing targeting vectors used to inactivate the endogenous p53 gene (10) was detected in p53 Ϫ/Ϫ epithelial cells used as control (Fig. 4, lane 1) ; in marked contrast, the pattern of hybridizing bands in eight different clones from Ki-ras-infected p53 Ϫ/Ϫ cells was rather heterogenous (Fig. 4, lanes 2-9) , consistent with the outgrowth of multiple, independently transformed cells after infection of p53 Ϫ/Ϫ epithelial cells with the Ki-rascontaining retrovirus.
Morphological characteristics and growth properties of p53-deficient, Ki-ras-infected colon epithelial cells.
After infection with the Ki-ras2 retroviral vector, the p53 Ϫ/Ϫ colon epithelial cells exhibited morphological features very similar to those of the parental noninfected cells. However, a greater number of cells with an elongated appearance was detected in the population of Ki-ras-infected cells (Fig. 1 C) . Often the cells exhibited a more refractile appearance, a typical feature of rapidly growing tumor cells. To determine if there were differences in the growth properties of noninfected and Ki-ras-infected p53 Ϫ/Ϫ colon epithelial cells, both cell types were assessed for proliferation in liquid culture and for colony formation in soft agar assays.
In three independent experiments, 10 4 cells were plated in triplicate 6-well dishes and counted 2 and 4 d after plating. Kiras-infected cells grew more rapidly than the parental, noninfected cells (data not shown). Of greater importance, in five independent experiments assessing growth in soft agar, only the Ki-ras-infected cells formed numerous, large colonies (Table  I) . We also assessed the invasive properties of Ki-ras-expressing colon epithelial cells by plating 6 ϫ 10 5 cells (parental, LXSN-infected, and Ki-ras-infected p53 Ϫ/Ϫ colon epithelial cells) into Biocoat ® Matrigel ® invasion chambers containing an 8-m pore size membrane. 24 h after plating, the number (triplicate experiment) of Ki-ras-infected p53 Ϫ/Ϫ colon epithelial cells on the lower surface of the membrane was four times that of control cells (data not shown).
Table I. Soft Agar Colony Formation Assays Using Parental and Ki-ras-infected p53 Ϫ/Ϫ Colon Epithelial Cells
To determine whether the transformation of Ki-ras-infected p53 Ϫ/Ϫ cells was dependent on the loss of p53 function, we investigated whether ectopic expression of wild-type p53 would suppress the growth of Ki-ras-infected p53 Ϫ/Ϫ cells. Wild-type p53 and the DNA binding deficient R248W mutant were cloned in a retroviral vector (LXSP) carrying the puromycin resistance gene and transfected into Ki-ras-infected p53 Ϫ/Ϫ cells. After a 2-wk selection in puromycin, the number of puromycin-resistant colonies arising from wild-type p53-transfected cells was markedly diminished as compared with that derived from cultures transfected with the DNA binding deficient mutant (Fig. 5) .
In vivo evaluation of tumor growth. The tumorigenic potential of parental p53-deficient epithelial cells or cells infected with the empty retroviral vector or with the mutant Ki-ras gene was assessed by injecting 10 6 cells subcutaneously in immunocompromised SCID mice (Table II) as well as in immunocompetent syngeneic mice (Table III) . By day 14, all of the mice injected with p53 Ϫ/Ϫ Ki-ras-infected cells produced subcutaneous tumors, whereas tumors were not detected in mice injected with parental or LXSN-infected p53 Ϫ/Ϫ epithelial cells (Tables II and III) . Of note, tumor formation from p53 Ϫ/Ϫ Ki-ras-infected cells was more rapid than that from the tumorigenic CMT-93 murine line used as positive control (data not shown). Histological analysis of the tumor xenografts produced by cells expressing the oncogenic Ki-ras exhibited classical features of infiltrating colon adenocarcinomas. First, there were areas ranging from moderately to well-differentiated adenocarcinoma (Fig. 6, A and B) and evidence of infiltration of the deep fascia and skeletal muscle (Fig. 6 C) . Nests of well-differentiated neoplastic cells forming gland-like structures were noted infiltrating the lymphatics (D) and in the perineural spaces. In addition, in some areas the tumor cells grew as solid cords and induced a prominent desmoplastic reaction with characteristic deposition of a collagenous matrix (Fig. 6, E and F) . Collectively, the growth pattern and the invasive properties of these neoplastic cells are fully supportive of their gastroenteric origin and in agreement with biological behavior known for these tumors. Of interest, tumor growth in mice was accompanied by persistent overexpression of the exogenous Ki-ras as indicated by Northern blot analysis (Fig. 7) .
The p53 Ϫ/Ϫ epithelial cells (parental and carrying the LXSN vector) were nontumorigenic even when injected in SCID mice after in vitro growth for 32 passages (data not shown).
Discussion
The multistep nature of colorectal tumorigenesis is a welldefined process based on the dissection of a preferred order of mutations in the normal, premalignant, and malignant colon mucosa. However, it has been difficult to maintain in culture primary epithelial cells from colon crypts, and this has ham- Table II. pered the direct assessment of the pathogenetic role of the various genetic lesions identified in colorectal cancer.
In this work, we have obtained cultures of primary epithelial cells from the colon crypts of p53-deficient mice. These cultures have been carried for several passages and are not tumorigenic, as indicated by their failure to form colonies in soft agar and tumors in immunodeficient or syngeneic hosts. In particular, after 32 passages, p53-deficient colon epithelial cells were still unable to form subcutaneous tumors in mice. By contrast, p53-deficient astrocytes appear to form tumors at earlier passages (24) and this correlates with an increase in the frequency of aneuploid cells.
Introduction of an activated Ki-ras gene in p53-deficient colon epithelial cells led to the rapid acquisition of a transformed phenotype as indicated by the ability of Ki-ras-infected cell to form colonies in soft agar, to exhibit high invasiveness in the in vitro assays designed for the assessment of this property, and to form tumors in immunodeficient and immunocompetent syngeneic hosts. The tumors formed in mice recapitulated the morphological features of colon adenocarcinomas and ex- hibited local invasion of the skeletal muscle, perineural spaces, and lymphatics. Of note, the tumor tissue of the xenografts exhibited elevated levels of Ki-ras expression, thus corroborating the causative role exerted by this oncogene upon a p53-deficient genetic background.
p53-deficient epithelial cells and the Ki-ras-transformed cells (at the 15th passage) were both highly aneuploid, as indicated by the identification of a normal chromosome number in only 20-25% of the metaphases that were examined (data not shown). Moreover, the frequency of polyploid metaphases was also indistinguishable in p53 Ϫ/Ϫ and Ki-ras-transformed epithelial cells (data not shown). The frequency of aneuploid cells in p53 Ϫ/Ϫ epithelial cells is very similar to that reported for astrocytes (24) and embryo fibroblasts (25) . Thus, it seems that the occurrence of secondary genetic abnormalities was not required for the Ki-ras-induced transformation of p53-deficient epithelial cells.
In this regard, loss of p53 function enables oncogenic proteins such as Myc, RAF, BCR/ABL, and RAS to exert their transformation potential (15, 26, 27) . In contrast, ectopic expression of oncogenic RAS in primary cells is associated with a transient stimulation of cell proliferation, followed by a permanent G1 arrest and features of early senescence (28) . The appearance of this phenotype is accompanied by accumulation of wild-type p53 and the p16 cyclin inhibitor (28) .
In our model of Ki-ras-induced neoplastic transformation of colon epithelial p53 Ϫ/Ϫ cells, reintroduction of wild-type p53 markedly suppressed colony formation (Fig. 5) . Thus, the results of this assay, which has long been used to investigate the tumor suppressor activity of p53 (13) , are consistent with the essential role of a null p53 background for Ki-ras-induced colorectal tumorigenesis.
The findings described here are similar to those obtained with an epithelial cell line derived from the colon of a mouse carrying a loss-of-function mutation of the APC (adenomatous polyposis coli) gene and ecotypically expressing the v-Ha-ras gene (29) . Loss of function mutations of the APC gene usually precede those involving Ki-ras and p53; however, colorectal tumorigenesis can also occur in the absence of APC mutations (2) . It is likely that the synergy between a mutant APC allele and v-Ha-ras activates a tumorigenic pathway distinct from that involving an activated Ki-ras gene in the context of a null p53 phenotype. While the APC gene is clearly involved in the early stages of colorectal tumorigenesis, mutations at the p53 locus are often associated with disease progression (1, 2) . Moreover, the effects of APC loss-of-function are largely restricted to colorectal epithelial cells (2) , while inactivating mutations at the p53 locus led to perturbation of cell cycle activity and enhanced susceptibility to apoptosis in many cell types. Thus, these two models of colorectal tumorigenesis can be exploited to identify pathways of gene expression specific for distinct stages of tumorigenesis. Moreover, these models can be used to compare the therapeutic effects of conventional and novel antitumor drugs. Figure 7 . Northern blot analysis of Ki-ras expression in Ki-rasinduced tumors. Total RNA (10 g/lane) was electrophoresed on a 1% denaturing agarose gel, transferred to Hybond-N membrane, and hybridized to a 32 P-labeled 1.1-kb BamHI-PstI fragment of the oncogenic human Ki-ras2 cDNA according to standard procedures. After stripping, the filter was hybridized with a glyceraldehyde-3-phosphate dehydrogenase (GADPH) probe as used as control for RNA loading. Lanes are as follows: 1, liver RNA from a p53 Ϫ/Ϫ mouse; 2, colon RNA from a p53 Ϫ/Ϫ mouse; 3, RNA from p53 Ϫ/Ϫ colon epithelial cells (18th passage); 4, RNA from Ki-ras-infected p53 Ϫ/Ϫ epithelial cells (18th passage); 5 and 6, RNA from subcutaneous tumors in two mice. The blot hybridized with the mutant Ki-RAS probe was exposed ‫ف‬ 16 h. After an exposure of 48 h, a faint hybridization band was also detected in lane 3.
